On February 7 2023, RocGene's independently developed Archimed Mini 16 Medical Fluorescence Quantitative PCR Instrument obtained the Class III Medical Device Registration Certificate by the National Medical Products Administration. ... Read More >

QIAGEN N.V. today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading tuberculosis (TB) blood test – under the European Union’s 2017/746 In Vitro Diagnostic Medical Devices Regulation (IVDR) which is replacing the 98/79/EC In Vitro Diagnos... Read More >

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 1, 2023. ... Read More >

On February 9, Sansure Bio released an announcement on the appointment of senior management personnel. Read More >

Abbott and Cardiovascular Systems, Inc. announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.... Read More >

DiaSorin and Cytek Biosciences, Inc. announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has signed an agreement with Cytek to sell substantially all of its assets related to the Flow Cytometry & Imaging business unit.... Read More >

On February 6, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and China Resources Pharmaceutical Commercial Group Co., Ltd. held a signing ceremony in the headquarter of Mindray in Shenzhen.... Read More >

Ibex Medical Analytics has received CE mark for its pathology diagnostics platform, Galen Prostate, under the European Union’s (EU) In Vitro Diagnostic Medical Devices Regulation (IVDR). ... Read More >

The US Food and Drug Administration on Wednesday granted Emergency Use Authorization for Anavasi Diagnostics' molecular point-of-care AscencioDx COVID-19 Test Kit.... Read More >

Recently, Sysmex and Shanghai Pinnacles Medical Technology Co., Ltd. reached a strategic cooperation. Read More >